X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20789) 20789
Newsletter (6254) 6254
Publication (1955) 1955
Newspaper Article (1477) 1477
Transcript (253) 253
Magazine Article (156) 156
Book Review (115) 115
Trade Publication Article (35) 35
Conference Proceeding (19) 19
Dissertation (14) 14
Book Chapter (9) 9
Data Set (3) 3
Book / eBook (2) 2
Paper (2) 2
Presentation (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
antimitotic agents (28493) 28493
antineoplastic agents (28418) 28418
cancer (18084) 18084
humans (14435) 14435
index medicus (13883) 13883
care and treatment (11584) 11584
oncology (8370) 8370
research (7335) 7335
female (7247) 7247
chemotherapy (7108) 7108
male (6144) 6144
health aspects (5860) 5860
analysis (5353) 5353
middle aged (4910) 4910
animals (4582) 4582
aged (4379) 4379
drug therapy (4334) 4334
pharmacology & pharmacy (3929) 3929
adult (3758) 3758
oncology, experimental (3739) 3739
antineoplastic agents - therapeutic use (3588) 3588
tumors (3165) 3165
medicine & public health (3156) 3156
metastasis (2942) 2942
treatment outcome (2899) 2899
cell line, tumor (2891) 2891
apoptosis (2889) 2889
antineoplastic combined chemotherapy protocols - therapeutic use (2600) 2600
drugs (2454) 2454
antineoplastic agents - pharmacology (2401) 2401
mice (2368) 2368
therapy (2184) 2184
medical research (2087) 2087
breast cancer (2083) 2083
cancer therapies (2039) 2039
reports (2020) 2020
clinical trials (2007) 2007
neoplasms - drug therapy (1951) 1951
genetic aspects (1948) 1948
hematology (1897) 1897
dosage and administration (1868) 1868
hematology, oncology and palliative medicine (1809) 1809
pharmaceutical industry (1725) 1725
aged, 80 and over (1671) 1671
cancer research (1664) 1664
cisplatin (1594) 1594
development and progression (1532) 1532
survival (1525) 1525
pharmacology/toxicology (1521) 1521
medicine, experimental (1479) 1479
expression (1452) 1452
prognosis (1447) 1447
proteins (1417) 1417
antineoplastic agents - administration & dosage (1384) 1384
radiotherapy (1342) 1342
cell proliferation - drug effects (1337) 1337
retrospective studies (1312) 1312
apoptosis - drug effects (1297) 1297
product development (1263) 1263
article (1262) 1262
cells (1258) 1258
leukemia (1247) 1247
paclitaxel (1240) 1240
physiological aspects (1240) 1240
universities and colleges (1238) 1238
intellectual property (1236) 1236
patients (1235) 1235
toxicity (1230) 1230
biochemistry & molecular biology (1214) 1214
dose-response relationship, drug (1214) 1214
in-vitro (1202) 1202
disease-free survival (1194) 1194
medical colleges (1178) 1178
carcinoma (1177) 1177
cytotoxicity (1112) 1112
antineoplastic agents - adverse effects (1099) 1099
surgery (1096) 1096
drug delivery systems (1091) 1091
drug resistance (1087) 1087
antineoplastic combined chemotherapy protocols - adverse effects (1079) 1079
usage (1076) 1076
angiogenesis (1073) 1073
complications and side effects (1054) 1054
trial (1043) 1043
nanoparticles (1042) 1042
studies (1024) 1024
antineoplastic agents - chemistry (1021) 1021
lung cancer, non-small cell (1020) 1020
breast-cancer (1002) 1002
lymphomas (1001) 1001
gene expression (996) 996
colorectal cancer (974) 974
melanoma (971) 971
immunotherapy (958) 958
cell survival - drug effects (944) 944
lung cancer (934) 934
kinases (931) 931
stem cells (925) 925
chemistry, medicinal (923) 923
growth (922) 922
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (28913) 28913
German (17) 17
French (11) 11
Italian (8) 8
Portuguese (2) 2
Chinese (1) 1
Japanese (1) 1
Korean (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10064, pp. 56 - 66
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 1/2010, Volume 102, Issue 1, pp. 14 - 25
Due to the aging of the populations of developed countries and a common occurrence of risk factors, it is increasingly probable that a patient may have both... 
DOXORUBICIN-INDUCED CARDIOTOXICITY | TRASTUZUMAB-RELATED CARDIOTOXICITY | ONCOLOGY | SPORADIC COLORECTAL ADENOMAS | VASCULAR-DISRUPTING AGENTS | TYROSINE KINASE INHIBITOR | N-ACETYLCYSTEINE | DAUNORUBICIN-INDUCED CYTOTOXICITY | HIGH-DOSE CHEMOTHERAPY | EARLY BREAST-CANCER | ATRIAL-FIBRILLATION | Atrial Fibrillation - chemically induced | Cardiovascular Diseases - prevention & control | Humans | Patient Care Team | Atrial Fibrillation - physiopathology | Ventricular Dysfunction, Left - chemically induced | Flavonoids - therapeutic use | Cardiotonic Agents - therapeutic use | Venous Thromboembolism - prevention & control | Cardiovascular System - physiopathology | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Antineoplastic Agents - adverse effects | Hypertension - chemically induced | Hypertension - prevention & control | Polyphenols | Free Radical Scavengers - therapeutic use | Acetylcysteine - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Adrenergic beta-Antagonists - therapeutic use | Cardiovascular Diseases - diagnosis | Heart - physiopathology | Cardiovascular Diseases - physiopathology | Stroke Volume - drug effects | Anticoagulants - therapeutic use | Cardiovascular System - drug effects | Hypertension - physiopathology | Ventricular Dysfunction, Left - physiopathology | Ventricular Dysfunction, Left - prevention & control | Cardiovascular Diseases - microbiology | Animals | Blood Coagulation - drug effects | Venous Thromboembolism - physiopathology | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Phenols - therapeutic use | Venous Thromboembolism - chemically induced | Heart - drug effects | Cardiovascular Diseases - chemically induced | Atrial Fibrillation - prevention & control | Antimitotic agents | Complications and side effects | Aging | Physiological aspects | Dosage and administration | Research | Cardiovascular diseases | Antineoplastic agents | Risk factors | Index Medicus | Review
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 700 - 712
Journal Article
Journal Article
Biochemical Pharmacology, ISSN 0006-2952, 09/2017, Volume 139, pp. 3 - 14
Marine sponges have consistently been the richest source of new marine natural products with unprecedented chemical scaffolds and potent biological activities... 
Porifera | Marine natural products | Drug discovery | ANDROGEN RECEPTOR | INOSITOL 5-PHOSPHATASE | MAST-CELLS | PAPUA-NEW-GUINEA | STRUCTURE ELUCIDATION | MARINE SPONGE | SHIP1 ACTIVATOR AQX-1125 | IN-VIVO | PHARMACOLOGY & PHARMACY | CYSTITIS/BLADDER PAIN SYNDROME | RESISTANT PROSTATE-CANCER | Indans - adverse effects | Anti-Asthmatic Agents - therapeutic use | Humans | Drugs, Investigational - therapeutic use | Antineoplastic Agents - therapeutic use | Prodrugs - chemistry | Nonsteroidal Anti-Androgens - chemistry | Oligopeptides - therapeutic use | Nonsteroidal Anti-Androgens - therapeutic use | Sterols - adverse effects | Glycerol - analogs & derivatives | Porifera - chemistry | Benzhydryl Compounds - therapeutic use | Oligopeptides - chemistry | Anti-Asthmatic Agents - chemistry | Glycerol - therapeutic use | Indans - chemistry | Anti-Asthmatic Agents - pharmacology | Pyrrolidinones - adverse effects | Antimitotic Agents - adverse effects | Pyrrolidinones - therapeutic use | Antimitotic Agents - therapeutic use | Biological Products - isolation & purification | Biological Products - chemistry | Pyrrolidinones - isolation & purification | Cyclohexanols - therapeutic use | Oligopeptides - pharmacology | Anti-Asthmatic Agents - adverse effects | Cyclohexanols - adverse effects | Drugs, Investigational - adverse effects | Drugs, Investigational - pharmacology | Anti-Inflammatory Agents, Non-Steroidal - chemistry | Oligopeptides - adverse effects | Indans - therapeutic use | Benzhydryl Compounds - chemistry | Drugs, Investigational - chemistry | Sterols - therapeutic use | Benzhydryl Compounds - adverse effects | Antineoplastic Agents - adverse effects | Cyclohexanols - chemistry | Nonsteroidal Anti-Androgens - adverse effects | Drug Design | Antineoplastic Agents - pharmacology | Glycerol - pharmacology | Aquatic Organisms - chemistry | Nonsteroidal Anti-Androgens - pharmacology | Sterols - pharmacology | Sterols - chemistry | Antineoplastic Agents - chemistry | Drug Discovery | Pyrrolidinones - chemistry | Prodrugs - adverse effects | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Antimitotic Agents - pharmacology | Benzhydryl Compounds - pharmacology | Prodrugs - therapeutic use | Prodrugs - pharmacology | Antimitotic Agents - chemistry | Chemical oceanography | Index Medicus
Journal Article